Search clinical trials for: Octagam 10%
Total 3145 results
-
OctapharmaCompletedImmune Thrombocytopenic PurpuraAustria
-
OctapharmaTerminatedImmunologic Deficiency SyndromesAustria
-
OctapharmaCompletedDermatomyositisUnited States, Poland, Canada, Czechia, Germany, Hungary, Netherlands, Romania, Russian Federation, Ukraine
-
IMMUNOe Research CentersOctapharmaUnknownPediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Pediatric Acute-Onset Neuropsychiatric SyndromeUnited States
-
Sharp HealthCareUnknownCovid19 | SARS-CoV InfectionUnited States
-
OctapharmaCompletedAlzheimer's DiseaseUnited States
-
Sutter HealthCompletedEffect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer DiseaseMild Cognitive ImpairmentUnited States
-
OctapharmaCompletedCovid-19United States, Russian Federation, Ukraine
-
OctapharmaCompletedPrimary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIGCanada, Austria, France, Spain, United Kingdom
-
Barts & The London NHS TrustBiosense Webster, Inc.Recruiting
-
Erasmus Medical CenterNot yet recruiting
-
OctapharmaCompleted
-
Ministry of Health and Population, EgyptCompletedPainful Diabetic NeuropathyEgypt
-
ClinAmygateAswan University HospitalRecruitingCholecystolithiasis | Cholecystitis; Gallstone | Cholecystitis, ChronicEgypt
-
Celularity IncorporatedCompletedDiabetic Foot | Peripheral Arterial DiseaseUnited States
-
Jas ChahalCompleted
-
Celularity IncorporatedTerminatedDiabetic Foot | Peripheral Arterial DiseaseUnited States
-
The Jackson LaboratoryUniversity of Alabama at Birmingham; UConn HealthCompletedPneumonia | AgingUnited States
-
Oslo University HospitalHelse Stavanger HFCompletedAcute Myocardial InfarctionNorway
-
Merry, Graham, M.D.CompletedNonexudative Age-related Macular DegenerationUnited States, Canada
-
BNM Clinic and ResearchCompletedDental Restoration, Permanent
-
Provectus Biopharmaceuticals, Inc.No longer availableCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative TherapyUnited States, Australia
-
Provectus PharmaceuticalsCompleted
-
Provectus PharmaceuticalsCompleted
-
University of North Carolina, Chapel HillRobert Wood Johnson FoundationCompleted
-
AerasEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Completed
-
Medical College of WisconsinThe New York Eye & Ear InfirmaryCompletedDiabetic Macular EdemaUnited States
-
Technical University of MunichUnknown
-
University Hospital, BonnOctapharma; Astellas Pharma GmbHUnknownRasmussen EncephalitisGermany
-
University of OxfordCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteProvectus PharmaceuticalsCompletedMelanomaUnited States
-
Armata Pharmaceuticals, Inc.Walter Reed Army Institute of Research (WRAIR)CompletedHealthy VolunteersUnited States
-
George Sakoulas, MDOctapharmaCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Mahidol UniversityPacific Health FoundationCompleted
-
Carina Biotech LimitedRecruitingColorectal Cancer MetastaticAustralia
-
State University of New York College of OptometryNational Eye Institute (NEI); Nova Southeastern University; University of Maryland...Unknown
-
Hanlim Pharm. Co., Ltd.CompletedPrimary Hypercholesterolemia
-
Merck Sharp & Dohme LLCCompletedBacterial Infections; Virus Diseases
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
NYU Langone HealthCompletedPatellar Femoral SyndromeUnited States
-
Bruce J GantzCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralUnited States
-
Aposense Ltd.CompletedSolid Tumors | Brain Metastases
-
Janssen Vaccines & Prevention B.V.Completed
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
LEO PharmaTerminatedAcute Respiratory Distress Syndrome | Acute Lung InjuryDenmark, Belgium, Austria, Canada, Finland, France, Germany, Netherlands, Norway, Spain, Sweden, United Kingdom